Reported 206,054 shares, down 172,953 (45.6%) from the prior quarter.
Reported value -50.5%; share count -45.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 23490000 |
| 2022-03-31 | 11629000 |
| 2022-06-30 | 0 |
| 2024-03-31 | 114083000 |
| 2024-06-30 | 78126000 |
| 2024-09-30 | 34274000 |
| 2024-12-31 | 34172000 |
| 2025-03-31 | 16499000 |
| 2025-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2025 | Reduced | 0 | -373,874 (-100.0%) | 0 | $0 | 2025-08-14 | |
| Q1 2025 | Reduced | 373,874 | -571,934 (-60.5%) | 0.06% | $16,499,000 | 2025-05-13 | |
| Q4 2024 | Reduced | 945,808 | -123,930 (-11.6%) | 0.11% | $34,172,000 | 2025-02-14 | |
| Q3 2024 | Reduced | 1,069,738 | -1,004,232 (-48.4%) | 0.11% | $34,274,000 | 2024-11-14 | |
| Q2 2024 | Reduced | 2,073,970 | -243,840 (-10.5%) | 0.26% | $78,126,000 | 2024-08-14 | |
| Q1 2024 | New | 2,317,810 | +2,317,810 (0.0%) | 0.37% | $114,083,000 | 2024-05-09 | |
| Q2 2022 | Reduced | 0 | -206,054 (-100.0%) | 0 | $0 | 2022-08-12 | |
| Q1 2022 | Reduced | 206,054 | -172,953 (-45.6%) | 0.03% | $11,629,000 | 2022-05-13 | |
| Q4 2021 | Added | 379,007 | +25,091 (7.1%) | 0.05% | $23,490,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
158 managers reported SPRINGWORKS THERAPEUTICS IN for Q1 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 6,046,209 | +2,099,889 | 0.03% | $341,248,036 | 11 qtrs |
| ORBIMED ADVISORS LLC | Unchanged | 6,028,307 | 0 | 5.59% | $340,238,000 | 11 qtrs |
| Bain Capital Life Sciences Investors LLC | Unchanged | 4,831,307 | 0 | 26.48% | $272,679,000 | 11 qtrs |
| PERCEPTIVE ADVISORS LLC | Reduced | 4,527,993 | -321,919 | 5.12% | $255,560,000 | 11 qtrs |
| VANGUARD GROUP INC | Added | 2,880,986 | +18,674 | < 0.01% | $162,602,000 | 11 qtrs |
| BlackRock Inc | Reduced | 2,303,279 | -58,373 | < 0.01% | $129,998,000 | 11 qtrs |
| Boxer Capital LLC | Unchanged | 2,075,905 | 0 | 6.02% | $117,164,000 | 11 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Added | 1,875,666 | +1,299,214 | 0.2% | $105,863,000 | 6 qtrs |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Added | 1,841,799 | +53,897 | 1.28% | $103,951,000 | 11 qtrs |
| Bank of America Corporation | Added | 1,627,487 | +113,114 | < 0.01% | $91,855,000 | 10 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2022
- Filed
- May 13, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 200,075
- Shared
- 0
- None
- 5,979
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.